Please note, only a limited number of applications will be accepted from each department (or division within the DOM) for each funding opportunity. Please seek approval with your department chair or division chief prior to submitting your application
Due to the COVID19 pandemic, the V Foundation has cancelled or postponed a number of their fundraising events, and expect overall fundraising to be reduced in 2020. Therefore they have made the difficult decision to withdraw the 2020 Translational grant (adult cancer types) Request for Applications (RFA), effective immediately.
Summary: Based on their performance during their education and training, candidates should demonstrate outstanding promise as contributors in science relevant to human health. Strong proposals will incorporate particularly creative and pioneering approaches. Strong proposals will incorporate particularly creative and pioneering approaches to basic, translational, and applied biomedical research.
Indirect Overhead Rate: Between 10% and 30% – see funding details below. When necessary, BWH will cover the difference to meet the 15% IDC minimum.
# of BWH nominations: One. To be nominated, you must submit an internal application here: http://bwhcfdd.partners.org/Listing.aspx?courseId=502. Only one application to one ADA Pathway Award will be accepted from each BWH department (or division within the Department of Medicine) to be considered for the BWH nominee. Please seek approval from your department chair or division chief before submitting your application.
Description: Pathway accepts nominations for exceptional investigators with medical and scientific backgrounds who propose innovative basic, clinical, translational, behavioral, epidemiological and health services research relevant to any type of diabetes, diabetes-related disease state or complication.
Initiator Award: Supports the transition of scientists from mentored training to independent research faculty.
Accelerator Award: Available to early-career diabetes investigators (who have not yet received a second R01) proposing innovative and ambitious diabetes-related research programs.
Visionary Award: Highly competitive award intended to support particularly innovative and transformational ideas that have the potential to have an exceptional impact in diabetes.
Summary: Clinical doctors and research scientists whose primary focus is breast cancer and who are in the early stages of their careers, are encouraged to apply. Applicants must (i) have held a faculty position for no more than four years following the completion of their training, as of February 1, 2021; (ii) have not been a principal investigator on an NIH R01 or equivalent national/international non-mentored award; and (iii) dedicate at least 50% of their work effort to research. This grant is intended to help advance the careers of young researchers who do not yet have their own major grant support. For clarity, current postdoctoral fellows who do not yet hold a faculty position are eligible to apply, provided they meet all the other stated criteria for Young Investigators.
Edward Mallinckrodt Foundation for research grant THE GUIDELINES FOR THIS GRANT CHANGED AS OF APRIL 20, 2016. INSTITUTIONS ARE NOW ONLY ALLOWED TO SUBMIT ONE APPLICATION. BWH IS NO LONGER ELIGIBLE TO APPLY FOR THIS GRANT SEPARATELY FROM HMS. THIS GRANT WILL BE PART OF THE HMS FOUNDATION FUND NOMINATION PROCESS GOING FORWARD